title: Evidence does not support clinically significant lenalidomide-CCI-779 interaction via P-glycoprotein.
authors.forename: Nianhang
authors.initials: N
authors.lastname: Chen
authors.forename: Claudia
authors.initials: C
authors.lastname: Kasserra
authors.forename: Gondi
authors.initials: G
authors.lastname: Kumar
authors.forename: Maria
authors.initials: M
authors.lastname: Palmisano
mesh_terms: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000378:metabolism*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D006801:Humans; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000378:metabolism*; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy* / Q000378:metabolism*
chemical_list: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1